Immediate Impact
2 by Nobel laureates 2 from Science/Nature 61 standout
Citing Papers
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
2022 Standout
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
2021 Standout
Works of DA Yardley being referenced
Abstract P3-12-04: A phase 2, multi-center, open label study evaluating the efficacy and safety of GRN1005 alone or in combination with trastuzumab in patients with brain metastases from breast cancer
2012
Phase III trial of sunitinib (SU) in combination with capecitabine (C) versus C in previously treated advanced breast cancer (ABC).
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| DA Yardley | 318 | 156 | 162 | 69 | 421 | |
| J-Y Pierga | 370 | 131 | 181 | 52 | 468 | |
| Yolanda Jerez | 283 | 80 | 96 | 30 | 407 | |
| Anne Patsouris | 261 | 144 | 99 | 51 | 394 | |
| Eleni Zografos | 222 | 107 | 150 | 40 | 463 | |
| Helmut Forstbauer | 348 | 120 | 155 | 53 | 405 | |
| Mohamed A. Gouda | 199 | 150 | 202 | 57 | 467 | |
| A. D. Seidman | 266 | 98 | 91 | 37 | 407 | |
| Steven Yip | 239 | 302 | 161 | 52 | 499 | |
| Silvia Antolín | 249 | 73 | 192 | 54 | 433 | |
| Carla Corvaja | 275 | 242 | 162 | 43 | 441 |
All Works
Loading papers...